Cargando…

Rare Non-Neuroendocrine Pancreatic Tumours

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma accounts for 85% of non-neuroendocrine pancreatic lesions. The remaining 15% consists of numerous diverse neoplasms, both malignant and benign. We gathered the latest data about the epidemiology, diagnosis, biomarkers and management of six rare pancre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mormul, Agata, Włoszek, Emilia, Nowoszewska, Julia, Fudalej, Marta, Budzik, Michał, Badowska-Kozakiewicz, Anna, Deptała, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136980/ https://www.ncbi.nlm.nih.gov/pubmed/37190144 http://dx.doi.org/10.3390/cancers15082216

Ejemplares similares

Diabetes Mellitus and Pancreatic Ductal Adenocarcinoma—Prevalence, Clinicopathological Variables, and Clinical Outcomes
por: Badowska-Kozakiewicz, Anna, et al.
Publicado: (2022)

Histopathological analysis of mucinous breast cancer subtypes and comparison with invasive carcinoma of no special type
por: Budzik, Michał Piotr, et al.
Publicado: (2021)

New Treatment Options in Metastatic Pancreatic Cancer
por: Fudalej, Marta, et al.
Publicado: (2023)

What is new about ovarian malignancies?
por: Grabska, Kinga, et al.
Publicado: (2021)

Assessment of Pain, Acceptance of the Disease, Adaptation to Life and Strategies for Coping with the Disease among Patients with Ovarian Cancer
por: Religioni, Urszula, et al.
Publicado: (2021)

Cancer-associated inflammation: pathophysiology and clinical significance
por: Pęczek, Piotr, et al.
Publicado: (2022)

How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review
por: Kwaśniewska, Daria, et al.
Publicado: (2023)

Medullary breast cancer is a predominantly triple-negative breast cancer – histopathological analysis and comparison with invasive ductal breast cancer
por: Budzik, Michał P., et al.
Publicado: (2019)

The complexity of tumour angiogenesis based on recently described molecules
por: Wiśniewska, Weronika, et al.
Publicado: (2021)

Clinicopathological factors associated with novel prognostic markers for patients with triple negative breast cancer
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2018)

Immunohistochemical characteristics of basal-like breast cancer
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2017)

Assessment of Pain, Acceptance of Illness, Adjustment to Life, and Strategies of Coping with Illness among Patients with Gastric Cancer
por: Religioni, Urszula, et al.
Publicado: (2019)

Evaluation of Nutritional Status and the Impact of Nutritional Treatment in Patients with Pancreatic Cancer
por: Mękal, Dominika, et al.
Publicado: (2023)

Current State of Knowledge on the Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer Treatment: Approaches, Efficacy, and Challenges
por: Uchimiak, Katarzyna, et al.
Publicado: (2022)

Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2016)

Quality of Life in Patients with Pancreatic Cancer—A Literature Review
por: Cipora, Elżbieta, et al.
Publicado: (2023)

Pulmonary blastoma in a pregnant woman: a case report and brief review of the literature
por: Budzik, Michał P., et al.
Publicado: (2022)

A rare case of concomittant pancreatic adenosquamous and neuroendocrine tumours
por: Vial, Izziddine, et al.
Publicado: (2022)

Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours
por: Mills, Logan, et al.
Publicado: (2017)

Mixed neuroendocrine-non-neuroendocrine tumour of pancreas mimicking groove pancreatitis: Case report
por: Dhali, Arkadeep, et al.
Publicado: (2021)

Non- pancreatic neuroendocrine tumour presenting with hypoglycemia in an elderly patient
por: Eren, Merve, et al.
Publicado: (2020)

Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality
por: Wu, Junjun, et al.
Publicado: (2019)

Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours
por: Balan, Mirela, et al.
Publicado: (2019)

Civil Lawsuits as an Indicator of Adverse Outcomes in Healthcare
por: Mikos, Marcin, et al.
Publicado: (2022)

Imaging in a rare case of neuroendocrine tumour with skin metastases
por: Białecki, Marcin, et al.
Publicado: (2018)

Double Hormone Syndromes in Two Pancreatic Neuroendocrine Tumours
por: Geoghegan, J. G., et al.
Publicado: (1996)

Unilateral Ptosis Caused by Pancreatic Neuroendocrine Tumour Metastases
por: Ueno, Tatsuya, et al.
Publicado: (2018)

Imitators of chronic pancreatitis: diffuse neuroendocrine tumour of the pancreas
por: Naringrekar, Haresh, et al.
Publicado: (2017)

Heterotopic pancreatic tissue masquerading as a neuroendocrine tumour
por: Koullouros, Michalis, et al.
Publicado: (2022)

The role of DNA methylation in human pancreatic neuroendocrine tumours
por: English, Katherine A, et al.
Publicado: (2023)

Functional and non-functional pancreatic neuroendocrine tumours: ENETS or AJCC TNM staging system?
por: Yang, Min, et al.
Publicado: (2017)

Expression of multidrug resistance protein P-glycoprotein in correlation with markers of hypoxia (HIF-1α, EPO, EPO-R) in invasive breast cancer with metastasis to lymph nodes
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2016)

Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2022)

Familial syndromes associated with neuroendocrine tumours
por: Gut, Paweł, et al.
Publicado: (2015)

Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours
por: Pipinikas, Christodoulos P, et al.
Publicado: (2015)

A Rare Case of Ectopic Adrenocorticotropic Hormone Secretion from Pancreatic Neuroendocrine Tumour Presenting with Cushing Syndrome
por: Lee, Soon Liang, et al.
Publicado: (2022)

Phase II study of single agent capecitabine in the treatment of metastatic non-pancreatic neuroendocrine tumours
por: Medley, L, et al.
Publicado: (2011)

Retrospective evaluation of histopathological examinations in invasive ductal breast cancer of no special type: an analysis of 691 patients
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2016)

Oesophageal neuroendocrine tumours—case series of a rare malignancy
por: Nikolic, Amanda L, et al.
Publicado: (2022)

Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
por: Lahner, Harald, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_faaec7as5shtj8s19gkc07iboo